Health Care Activity
23andMe Shifts Focus to GLP-1 Telehealth Offering, Cuts Internal Drug Development Team
23andMe, GLP-1, telehealth, weight loss, drug development, layoffs
Novo Nordisk Expands Legal Campaign Against Compounders of GLP-1 Drugs
Novo Nordisk, GLP-1 drugs, compounded drugs, legal campaign, patient safety, semaglutide
Galapagos Halts CAR-T Cell Therapy Trial Due to Parkinsonism Case
Galapagos, CAR-T cell therapy, Parkinsonism, clinical trial, patient enrollment, BCMA-directed therapy, multiple myeloma
Teladoc Posts $838M Loss in Q2, Announces Strategic Pivot for BetterHelp
Teladoc, BetterHelp, Q2 loss, strategic pivot, telehealth, virtual healthcare
Incyte Discontinues Five Early-Stage Oncology Programs in Pipeline Refocus
Incyte, cancer pipeline, oncology programs, PD-L1 inhibitors, strategic review, R&D refocus
Dexcom Stock Plummets 40% After Disappointing CGM Sales and Weak Guidance
Dexcom, CGM, Sales Challenges, Stock Drop, Weak Guidance
NewAmsterdam Achieves Success in First of Three Pivotal Cardio Studies
NewAmsterdam, pivotal studies, cardio class, pharmaceuticals, medical breakthrough
FDA Halts vTv Therapeutics’ Type-1 Diabetes Clinical Trial Due to Chromatographic Signal
vTv Therapeutics, FDA, clinical trial, type-1 diabetes, cadisegliatin, chromatographic signal, patient safety, glucokinase activator
President Biden Highlights Achievements in Lowering Prescription Drug Costs as He Steps Down from Re-election Campaign
President Biden, drug pricing, re-election campaign, Medicare, Inflation Reduction Act, prescription drug costs, health care costs, pharmaceutical industry
PBM Executives Avoid Tough Questions in House Committee Hearing
PBM executives, House committee hearing, pharmacy benefit managers, CVS Caremark, Express Scripts, Optum Rx